EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Defenestration of Liver Sinusoidal Endothelial Cells: The Trigger of Liver Fibrosis

Juntao Zhou, Jianqiao Wang, Lijuan Zhang, Chengliang Zhang iD, Cheng Tian iD

Pharmaceuticals · 14.06.2025 · 18 (6) · 893

DOI: 10.3390/ph18060893 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 14.06.2025. Verfasst von Juntao Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis is a common pathological manifestation of various chronic liver diseases, distinguished by the excessive accumulation of the extracellular matrix. If unresolved, liver fibrosis can progress to cirrhosis or hepatocellular carcinoma. Fenestrae are important structures of liver sinusoidal endothelial cells (LSECs) regulating hepatic substance exchange, immune response and hemodynamics. The loss of this structure is usually accompanied by dysfunction of LSECs, which disrupts normal liver physiology by impairing hepatic substance exchange, compromising liver microcirculation, and activating hepatic stellate cells (HSCs). This cascade of events ultimately contributes to the onset and development of liver fibrosis. Oxidative stress, impairment of the NO signaling pathway, actin–myosin complex remodeling and pathological angiogenesis are considered to be the main mechanisms underlying LSEC defenestration. Recently, research on the treatment of LSEC defenestration has made notable progress, and findings suggest a potential value in the application of anti-fibrotic therapies. This article expounds the important correlation between defenestration of LSECs and liver fibrosis, while also reviews therapeutic agents and approaches targeting this pathological process.

Schlagwörter

Stichwörter der Autor:innen

capillarizationfenestraeliver fibrosisliver sinusoidal endothelial cellsoxidative stresspathological angiogenesistherapeutic strategies

Autor:innen und Institutionen

  • Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

ORCID-Profile: Chengliang Zhang, Cheng Tian

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, J., Wang, J., Zhang, L., Zhang, C., & Tian, C. (2025). Defenestration of Liver Sinusoidal Endothelial Cells: The Trigger of Liver Fibrosis. Pharmaceuticals, 18(6), 893. https://doi.org/10.3390/ph18060893

Vancouver

Zhou J, Wang J, Zhang L, Zhang C, Tian C. Defenestration of Liver Sinusoidal Endothelial Cells: The Trigger of Liver Fibrosis. Pharmaceuticals. 2025;18(6):893. doi:10.3390/ph18060893

BibTeX
@article{Zhou2025,
  author = {Zhou, Juntao and Wang, Jianqiao and Zhang, Lijuan and Zhang, Chengliang and Tian, Cheng},
  title = {Defenestration of Liver Sinusoidal Endothelial Cells: The Trigger of Liver Fibrosis},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {6},
  pages = {893},
  doi = {10.3390/ph18060893}
}
Kostenlos starten →